홈MCP워크벤치Skills
홈워크벤치알림마이페이지
Huagongshe 오픈 프로젝트:[email protected]AI 접속: llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.7.8
돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HCID 11025생성일: 2026년 10월 27일

납 테트라아세트산

납테트라아세트산 · 납테트라아세트산(LEADTETRAACETATE) · 테트라아세트산 납 · 납 테트라아세테이트 · 납(IV) 아세테이트 · 아세트산 납 (Pb(O2C2H3)4) · 아세트산 납(IV) · 아세트산 제이납

https://huagongshe.com/ko/chemical/11025

납 테트라아세트산 분자 구조식

식별자 및 물리적 특성

CAS No.546-67-8
분자식C8H12O8Pb-2
평균 분자량443 g/mol
SMILESCC(=O)[O-].CC(=O)[O-].CC(=O)[O-].CC(=O)[O-].[Pb+2]
InChIKeyACKFDYCQCBEDNU-UHFFFAOYSA-J
PubChem CID11025
EC No.208-908-0
현지명납 테트라아세트산

화학 및 물리적 성질

극성 표면적161
수소 결합 공여자 수0
수소 결합 수용자 수8
회전 가능 결합 수0
무거운 원자 수17
형식 전하-2
복잡도25.5
물질 분류Metals -> Organic Acids, Metal Salts
냄새LIKE ACETIC ACID OR VINEGAR
밀도2.2 at 68 °F (USCG, 1999) - Denser than waterwill sink2.228 at 17 °C/4 °C2,28 g/cm3
Color/FormColorless monoclinic prisms from glacial acetic acidColorless or faintly pink crystals, sometimes moist with glacial acetic acid
용해도Soluble in hot glacial acetic acid, benzene, chloroform, tetrachloroethane, nitrobenzene.에 용해됨클로로포름, 메탄올 (약간 용해됨)
CorrosivityMAY CORRODE METALS WHEN MOIST
DecompositionHazardous decomposition products formed under fire conditions: Carbon oxides, lead oxides.
녹는점347 °F (USCG, 1999)175-180 °C
Physical DescriptionFaintly pink wet crystals with an odor of vinegar. (USCG, 1999)Colorless to pink solid from glacial acetic acid[Merck Index # 5423]
Stability/Shelf LifeUnstable in air
Other Experimental PropertiesTurns pink easily. Unstable in air. Hydrolyzed by water with the formation of brown lead dioxide and acetic acid. Dissolves in concd halogen acids with the formation of haloplumbic acids, H2PbX6.Lead is derived from the decay of radon. /Inorganic lead/Natural lead is a mixture of four stable isotopes: Pb-204 (1.4%), Pb-206 (25.2%), Pb-207 (21.7%) and Pb-208 (51.7%). Lead isotopes are the end-products of each of the three series of naturally occurring radioactive elements: Pb-206 for the uranium series, Pb-207 for the actinium series and Pb-208 for the thorium series. Forty-three other isotopes of lead, all of which are radioactive, are recognized.
끓는 점118.1°C
저장 조건Inert atmosphere,2-8°C
물리적 상태결정성 분말
색상흰색에서 밝은 주황색-분홍색
비중2.28
용해도분해
Merck14,5423
BRN3595640
안정성안정적인. 수분에 민감합니다. 물, 대부분의 금속과 호환되지 않습니다.
InChI1S/4C2H4O2.Pb/c4*1-2(3)4/h4*1H3,(H,3,4)/q+4/p-4
InChIKeyJEHCHYAKAXDFKV-UHFFFAOYSA-J
SMILESCC(=O)O[Pb](OC(C)=O)(OC(C)=O)OC(C)=O
NISTLead tetraacetate(546-67-8)
EPALead(IV) acetate (546-67-8)

화학적 성질

Lead tetraacetate (plumbic acetate), Pb(C2H3O2)4, is a colorless, monoclinic crystalline solid that is soluble in chloroform and in hot acetic acid, but decomposes in cold water and in ethyl alcohol. Lead tetraacetate can be prepared by adding warm, water-free, glacial acetate acid to red lead, Pb3O4, and subsequent cooling. The salt decomposes with the addition of water to give PbO2, but the yield can be improved by passing in chlorine gas. Lead tetraacetate is available in laboratory quantities as colorless to faintly pink crystals stored in glacial acetic acid.

안전 및 규제

GHS 분류DangerH302+H332 (59.3%): Harmful if swallowed or if inhaled [Warning Acute toxicity, oralacute toxicity, inhalation]P203, P260, P261, P264, P270, P271, P273, P280, P301+P317, P304+P340, P317, P318, P319, P330, P391, P405, and P501 (click each P-code to see the statement)Aggregated GHS information provided per 177 reports by companies from 8 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.H302: Harmful if swallowed [Warning Acute toxicity, oral]
규제 정보Chemical: Acetic acid, lead(4+) saltStatus: Cease Manufacture Update: 02-11-2010 https://echa.europa.eu/registration-dossier/-/registered-dossier/1560Restricted substance: Lead tetraacetateLead tetraacetate: HSNO Approval: HSR006169 Approved with controls
기타 안전 정보IMAP assessments - Lead acetates: Human health tier II assessment
운송 라벨(DOT)Poison
화재 위험Behavior in Fire: Can increase the intensity of a fire when in contact with combustible material. Cool containers with plenty of water. (USCG, 1999)
화재 가능성Not flammable ... Can increase intensity of fire when in contact with combustible material.
건강 유해성Early symptoms of lead intoxication by ingestion are most commonly gastrointestinal disorders, colic, constipation, etc.weakness, which may go on to paralysis chiefly of the extensor muscles of the wrists and less often of the ankles, is noticeable in the most serious cases. Ingestion of a large amount causes local irritation of the alimentary tractpain, leg cramps, muscle weakness, paresthesias, depression, coma, and death may follow in 1 or 2 days. Contact causes severe irritation of eyes and can burn skin. (USCG, 1999)
유해성 요약Contact causes severe irritation of eyes and can burn skin[CAMEO] Toxic substance that can be absorbed through skin[Hawley] See Lead and linked occupational diseases.
반응성 그룹Oxidizing Agents, Strong
Special Reports

용도

개요

Lead (IV) acetate or lead tetraacetate is a chemical compound with chemical formula Pb(C2H3O2)4 and is a lead salt of acetic acid. It is commercially available often stabilized with acetic acid.

용도

Oxidation with lead tetraacetate is often used in organic syntheses, because the lead salt is highly selective in the splitting of vicinal glycols. The rate of oxidation of cis glycols is more rapid than of the trans isomers, a property widely used in the structural determination of sugars and other polyols. Lead tetraacetate readily cleaves α-hydroxy acids as oxalic acid at room temperature. Another use is the introduction of acetoxy groups in organic molecules, as in the preparation of cyclohexyl acetate and the acetoxylation of cyclohexanol. At high temperature, methylation takes place. In these reactions, the organic molecule must contain double bonds or activating substituents.

일반 설명

Faintly pink wet crystals with an odor of vinegar.

제조 및 합성 방법

제조 방법

Lead tetraacetate can be prepared by reaction of red lead with acetic acid The other main lead acetate is lead (II) acetate.

National Toxicology Program. Eleventh Report on Carcinogens (2005). The Report on Carcinogens is an informational scientific and public health document that identifies and discusses substances (including agents, mixtures, or exposure circumstances) that may pose a carcinogenic hazard to human health. Lead and Lead Compounds are listed as reasonably anticipated to be human carcinogens. /Lead and Lead Compounds/[Available from, as of July 31, 2009: http://ntp.niehs.nih.gov/ntp/roc/eleventh/profiles/s101lead.pdf]
RCRA 요건D008A solid waste containing lead may or may not become characterized as a hazardous waste when subjected to the Toxicity Characteristic Leaching Procedure listed in 40 CFR 261.24, and if so characterized, must be managed as a hazardous waste. /Lead/The Environmental Protection Agency is ... /promulgated/ regulations concerning ground-water monitoring with regard to screening suspected contamination at land based hazardous waste treatment, storage, and disposal facilities. ... /There are/ new requirements to analyze for a specified core list of chemicals plus those chemicals specified by the Regional Administrator on a site-specific basis. ... /Total lead (all species) is included on this list./ /Total lead (all species)/
Reactivity AlertsStrong Oxidizing Agent
OSHA StandardsBlood lead levels of 50-60 ug/100 g in children can cause significant neurobehavioral impairments, and there is evidence of hyperactivity at blood levels as low as 25 ug/100 g. Given the overall body of literature concerning the adverse health effects of lead in children, OSHA feels that the blood level in children should be maintained below 30 ug/100 g with a population mean of 15 ug/100 g. Blood lead levels in the fetus and newborn likewise should not exceed 30 ug/100 g. /Lead/
소화Excerpt from ERG Guide 151 [Substances - Toxic (Non-Combustible)]:
응급 처치Remove at once all cases of lead intoxication from further exposure until the blood level is reduced to a safe valueimmediately place the individual under medical care.
노출 관리 및 개인 보호Biological Exposure Indices (BEI) [ACGIH] - Lead in blood = 200 ug/L (20 ug/100 ml)sampling time not critical
소화 절차Cool containers with plenty of water.
보관 조건Dry material can be stored in sealed, evacuated ampules.Keep container tightly closed in a dry and well-ventilated place. Recommended storage temperature: 2 - 8 °C. Store under inert gas. Air and moisture sensitive.
정리 방법Prevent further leakage or spillage if safe to do so. Do not let product enter drains. Discharge into the environment must be avoided. Pick up and arrange disposal without creating dust. Keep in suitable, closed containers for disposal.
비화재 누출 대응Neutralizing Agents for Acids and Caustics: Dilute with water, rinse with dilute sodium bicarbonate or lime solution. (USCG, 1999)
처리 방법Generators of waste (equal to or greater than 100 kg/mo) containing this contaminant, EPA hazardous waste number D008, must conform with USEPA regulations in storage, transportation, treatment and disposal of waste. /Lead/
Preventive MeasuresSRP: The scientific literature for the use of contact lenses in industry is conflicting. The benefit or detrimental effects of wearing contact lenses depend not only upon the substance, but also on factors including the form of the substance, characteristics and duration of the exposure, the uses of other eye protection equipment, and the hygiene of the lenses. However, there may be individual substances whose irritating or corrosive properties are such that the wearing of contact lenses would be harmful to the eye. In those specific cases, contact lenses should not be worn. In any event, the usual eye protection equipment should be worn even when contact lenses are in place.SRP: Local exhaust ventilation should be applied wherever there is an incidence of point source emissions or dispersion of regulated contaminants in the work area. Ventilation control of the contaminant as close to its point of generation is both the most economical and safest method to minimize personnel exposure to airborne contaminants.SRP: Contaminated protective clothing should be segregated in a manner so that results in no direct personal contact by personnel who handle, dispose of, or clean the clothing. Quality assurance procedures to confirm the efficacy of the cleaning procedures should be implemented prior to the decontaminated protective clothing being returned for reuse by the workers. Contaminated clothing (including shoes/socks) should not be taken home at end of shift, but should remain at employee's place of work for cleaning.SRP: Wastewater from contaminant suppression, cleaning of protective clothing/equipment, or contaminated sites should be contained and evaluated for subject chemical or decomposition product concentrations. Concentrations shall be lower than applicable environmental discharge or disposal criteria. Alternatively, pretreatment and/or discharge to a permitted wastewater treatment facility is acceptable only after review by the governing authority and assurance that "pass through" violations will not occur. Due consideration shall be given to remediation worker exposure (inhalation, dermal and ingestion) as well as fate during treatment, transfer and disposal. If it is not practicable to manage the chemical in this fashion, it must be evaluated in accordance with EPA 40 CFR Part 261, specifically Subpart B, in order to determine the appropriate local, state and federal requirements for disposal.For more Preventive Measures (Complete) data for LEAD TETRAACETATE (7 total), please visit the HSDB record page.
Isolation and EvacuationExcerpt from ERG Guide 151 [Substances - Toxic (Non-Combustible)]:
Minimum Risk LevelChronic Inhalation: 0.05 mg/m3 (L134)
Threshold Limit Values (TLV)0.05 [mg/m3], as Pb8 hr Time Weighted Avg (TWA): 0.05 mg/cu m. /Lead and inorganic compounds, as Pb/Excursion Limit Recommendation: Excursions in worker exposure levels may exceed 3 times the TLV-TWA for no more than a total of 30 minutes during a work day, and under no circumstances should they exceed 5 times the TLV-TWA, provided that the TLV-TWA is not exceeded. /Lead and inorganic compounds, as Pb/A3Confirmed animal carcinogen with unknown relevance to humans. /Lead and inorganic compounds, as Pb/Biological Exposure Index (BEI): Determinant: lead in bloodSampling Time: not criticalBEI: 30 ug/100 mL. [Note: Women of child bearing potential, whose blood Pb exceeds 10 ug/dL, are at risk of delivering a child with a blood Pb over the current Centers for Disease Control guideline of 10 ug/dL. If the blood Pb of such children remains elevated, they may be at increased risk of cognitive deficits. The blood Pb of these children should be closely monitored and appropriate steps should be taken to minimize the child's exposure to environmental lead.] /Lead/
TreatmentLead poisoning is usually treated with chelation therapy using DMSA, EDTA, or dimercaprol. (L21)
상호 작용The usefulness of N-acetylcysteine (NAC) as a chelating agent was studied for ... lead tetraacetate. Mature Sprague-Dawley rats were intoxicated ... and placed in metabolic cages. Urinary excretion rates of intoxicant and total urine volume were determined during treatment with N-acetylcysteine, calcium EDTA, and/or dimercaptosuccinic acid .... Dimercaptosuccinic acid was most effective at the chelation of lead. NAC did not increase the excretion of lead ...
건강 영향Lead is a neurotoxin and has been known to cause brain damage and reduced cognitive capacity, especially in children. Lead exposure can result in nephropathy, as well as blood disorders such as high blood pressure and anemia. Lead also exhibits reproductive toxicity and can results in miscarriages and reduced sperm production. (L21)
유해 작용Neurotoxin - Predominantly motor
노출 경로Oral (L136)inhalation (L136)dermal (L136)
독성 요약Lead mimics other biologically important metals, such as zinc, calcium, and iron, competing as cofactors for many of their respective enzymatic reactions. For example, lead has been shown to competitively inhibit calcium's binding of calmodulin, interferring with neurotransmitter release. It exhibits similar competitive inhibition at the NMDA receptor and protein kinase C, which impairs brain microvascular formation and function, as well as alters the blood-brain barrier. Lead also affects the nervous system by impairing regulation of dopamine synthesis and blocking evoked release of acetylcholine. However, it's main mechanism of action occurs by inhibiting delta-aminolevulinic acid dehydratase, an enzyme vital in the biosynthesis of heme, which is a necesssary cofactor of hemoglobin. (T4, A20, A22, L136)
생태독성 발췌/AQUATIC SPECIES/ Very toxic to aquatic organisms, may cause long-term adverse effects in the aquatic environment.
Signs and SymptomsSymptions of chronic lead poisoning include reduced cognitive abilities, nausea, abdominal pain, irritability, insomnia, metal taste in the mouth, excess lethargy or hyperactivity, chest pain, headache and, in extreme cases, seizures, comas, and death. There are also associated gastrointestinal problems, such as constipation, diarrhea, vomiting, poor appetite, weight loss, which are common in acute poisoning. (A2, L21)
Carcinogen ClassificationOrganic lead compounds are not classifiable as to their carcinogenicity to humans (Group 3). To the extent that organic lead compounds are metabolized in part to ionic lead, they are expected to exert the toxicities associated with inorganic lead (Group 2A, probably carcinogenic to humans). (L135)
Non-Human Toxicity Excerpts/LABORATORY ANIMALS: Acute Exposure/ IV admin to /mixed breed/ dogs produced acute syndrome of lead intoxication, vomiting, anorexia, and wt loss./GENOTOXICITY/ 7 chemicals commonly found at the industrial waste sites were tested with the Tradescantia-Micronucleus (Trad-MCN) assay to evaluate their clastogenic potential. Chemicals selected from the US EPA Superfund Priority 1 list /included/ lead tetraacetate. Results of repeated tests for clastogenicity yielded the minimum effective dose (MED) for clastogenicity of 0.44 ppm for lead tetraacetate .../GENOTOXICITY/ Synergistic and antagonistic effects on genotoxicity of mixtures of four chemicalsi.e., lead tetraacetate (LTA), arsenic trioxide (ATO), dieldrin (DED), and tetrachloroethylene (TCE), were evaluated by the Tradescantia-Micronucleus (Trad-MCN) assay. The chemicals were mixed in ratios of 1:1, 1:2 and 2:1 for mixtures of two chemicals and 1:1:1 each for three chemicals. The concn of stock solution of these chemicals was around the minimum effective dose (MED) or below the MED for these chemicals ... Treatments were applied to plant cuttings by hydroponic uptake of the mixed solutions through the stems of the plant for 30 hr followed by fixation of the flower buds in aceto-alcohol (1:3 ratio) without a recovery period. Microslides were prepared for scoring MCN frequencies. Results of two series of repeated experiments indicated that all mixtures of LTA/ATO exhibited antagonistic effects. On the other hand, all mixtures of TCE and DED exhibited synergistic effect ...
Evidence for CarcinogenicityLead, lead compounds: Reasonably anticipated to be a human carcinogenA3Confirmed animal carcinogen with unknown relevance to humans. /Lead, elemental, and inorganic compounds, as Pb/
Antidote and Emergency TreatmentImmediate first aid: Ensure that adequate decontamination has been carried out. If patient is not breathing, start artificial respiration, preferably with a demand-valve resuscitator, bag-valve-mask device, or pocket mask, as trained. Perform CPR as necessary. Immediately flush contaminated eyes with gently flowing water. Do not induce vomiting. If vomiting occurs, lean patient forward or place on left side (head-down position, if possible) to maintain an open airway and prevent aspiration. Keep patient quiet and maintain normal body temperature. Obtain medical attention. /Lead and related compounds/Basic treatment: Establish a patent airway (oropharyngeal or nasopharyngeal airway, if needed). Suction if necessary. Watch for signs of respiratory insufficiency and assist ventilations if necessary. Administer oxygen by nonrebreather mask at 10 to 15 L/min. Monitor for shock and treat if necessary ... . Anticipate seizures and treat if necessary ... . For eye contamination, flush eyes immediately with water. Irrigate each eye continuously with 0.9% saline (NS) during transport ... . Do not use emetics. For ingestion, rinse mouth and administer 5 ml/kg up to 200 ml of water for dilution if the patient can swallow, has a strong gag reflex, and does not drool ... . Administer activated charcoal ... . /Lead and related compounds/Advanced treatment: Consider orotracheal or nasotracheal intubation for airway control in the patient who is unconscious or is in severe respiratory distress. Moderate hyperventilation (20 respiration per minute) may be beneficial for increased intracranial pressure. Start IV administration of 0.9% saline (NS) or lactated Ringer's (LR) /SRP: "To keep open", minimal flow rate/. For hypotension ... . Treat seizures with diazepam or lorazepam ... . Use proparacaine hydrochloride to assist eye irrigation ... . /Lead and related compounds/Treatment. Emergency and supportive measures. Treat seizures and coma if they occur. Provide adequate fluids to maintain urine flow but avoid overhydration, which may aggravate cerebral edema. Avoid phenothiazines for delirium , as they may lower the seizure threshold. Patients with increased intracranial pressure may benefit from corticosteroids and mannitol. /Lead/For more Antidote and Emergency Treatment (Complete) data for LEAD TETRAACETATE (6 total), please visit the HSDB record page.
대기 기준National primary and secondary ambient air quality standards for lead and its compounds, measured as elemental lead by a reference method based on appendix G to this part, or by an equivalent method, are: 1.5 micrograms per cubic meter, maximum arithmetic mean averaged over a calendar quarter. /Lead and its compounds, as Pb/Listed as a hazardous air pollutant (HAP) generally known or suspected to cause serious health problems. The Clean Air Act, as amended in 1990, directs EPA to set standards requiring major sources to sharply reduce routine emissions of toxic pollutants. EPA is required to establish and phase in specific performance based standards for all air emission sources that emit one or more of the listed pollutants. Lead compounds are included on this list. /Lead compounds/
청정수법 요건Toxic pollutant designated pursuant to section 307(a)(1) of the Federal Water Pollution Control Act and is subject to effluent limitations. /Lead and compounds/
State Drinking Water Standards(AZ) ARIZONA 50 ug/L /Lead/
주 식수 지침(AZ) ARIZONA 20 ug/L /Lead/(ME) MAINE 10 ug/L /Lead/
Federal Drinking Water StandardsEPA 15 ug/L (Action Level) /Lead/
수질 위해 등급(WGK)3
TSCA 등재 상태TSCA listed
RTECS 번호AI5300000
운송 번호(UN)UN 2923 8/PG 2
관세 코드29152900
위험 문구(R)61-8-20/22-33-35-50/53-62
위험 표시T,N,O
안전 문구(S)53-45-60-61-36/37/39-26-17
포장분류III
위험 등급6.1Acute Tox. 4 InhalationAcute Tox. 4 OralAquatic Acute 1Aquatic Chronic 1Repr. 1ASTOT RE 2
기존화학 물질KE-21946
F 고인화성물질10-21
저장 분류6.1C - Combustible acute toxic Cat.3toxic compounds or compounds which causing chronic effects
유해 물질 데이터546-67-8(Hazardous Substances Data)
함량 및 규제정보물질구분: 유독물질혼합물(제품)함량정보: 사산화납(lead tetraoxide), 황산납(lead sulfate), 염기성탄산납(basic lead carbonate)을 제외한 납화합물(Lead compounds) 및 이를 25% 이상 함유한 혼합물. 다만, 초산납(lead acetate), 알킬화납(lead alkyls), 아지드화납(lead azide), 이초산납(lead di(acetate)), 메탄술폰산납(lead(Ⅲ) methansulfonate), 인산납(lead phosphate(3:2)), 스티핀산납(lead styphate)의 경우는 이를 0.5% 이상 함유한 혼합물
유해화학물질 필터링97-1-9
중점관리물질 필터링별표2-67
암, 돌연변이성물질 필터링296